Zhuhai Fapon Biopharma Co., Ltd.

This early-phase study tests a new drug called FP008 in people with advanced solid tumors that have not responded to other treatments. The main goal is to check safety and find the right dose. About 108 adults will take part, and researchers will also look at how the drug works i…